CVS Group (CVSG)

Sector:

Retailers

Index:

FTSE AIM 50

 1,276.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 1,424.00
  • 52 Week Low: 818.00
  • Currency: UK Pounds
  • Shares Issued: 70.69m
  • Volume: 0
  • Market Cap: £902.02m
  • RiskGrade: 136
  • Beta: 0.96

Total Voting Rights

By Sharecast

Date: Wednesday 31 Dec 2025

RNS Number : 2067N
CVS Group plc
31 December 2025
 



31 December 2025


CVS Group plc


("CVS" or the "Company")


Total Voting Rights



CVS, the UK's listed veterinary group and a leading provider of veterinary services, announces that, as of 31 December 2025, following cancellation of the Ordinary Shares purchased pursuant to the Company's share buyback programme (announced on 24 October 2025) prior to the date of this announcement, the Company's total issued share capital will consist of 70,711,273 ordinary shares of 0.2p each ("Ordinary Shares").


This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.


 


Contacts:


CVS Group plc                                                                                                        via Camarco


Richard Fairman, CEO


Robin Alfonso, CFO


Paul Higgs, Chief Veterinary Officer


Charlotte Page, Head of Investor Relations


 


Peel Hunt LLP (Nominated Adviser & Joint Broker)                                         +44 (0)20 7418 8900


Christopher Golden / James Steel / Andrew Clark 


 


  Berenberg (Joint Broker)                                                                                        +44 (0)20 3207 7800


Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing


 


Camarco (Financial PR)                                                                                             


Ginny Pulbrook                                                                                                          +44 (0)7961 315 138


Letaba Rimell


Tilly Butcher


 


About CVS Group plc (www.cvsukltd.co.uk)


CVS Group is an AIM-listed provider of veterinary services with operations in the UK and Australia.  CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.


 


The Group now operates c.470 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business ("Animed Direct").


 


The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.


 






This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRPKKBPBBDBFBN

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

CVS Group Market Data

Currency UK Pounds
Share Price 1,276.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 1,424.00
52 Week Low 818.00
Volume 0
Shares Issued 70.69m
Market Cap £902.02m
Beta 0.96
RiskGrade 136

CVS Group Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
51.91% below the market average51.91% below the market average51.91% below the market average51.91% below the market average51.91% below the market average
77.14% below the sector average77.14% below the sector average77.14% below the sector average77.14% below the sector average77.14% below the sector average
Price Trend
25.69% above the market average25.69% above the market average25.69% above the market average25.69% above the market average25.69% above the market average
22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average
Income
94.41% below the market average94.41% below the market average94.41% below the market average94.41% below the market average94.41% below the market average
91.3% below the sector average91.3% below the sector average91.3% below the sector average91.3% below the sector average91.3% below the sector average
Growth
16.48% below the market average16.48% below the market average16.48% below the market average16.48% below the market average16.48% below the market average
38.89% above the sector average38.89% above the sector average38.89% above the sector average38.89% above the sector average38.89% above the sector average

What The Brokers Say

Strong Buy 5
Buy 2
Neutral 3
Sell 0
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CVS Group Dividends

  Latest Previous
  Final Final
Ex-Div 06-Nov-25 31-Oct-24
Paid 05-Dec-25 29-Nov-24
Amount 8.50p 8.00p

Trades for --2026

Time Volume / Share Price
0 @ 0.000p

CVS Group Key Personnel

CEO Richard Fairman
Finance Director Robin Alfonso

Top of Page